Skip to main content
. 2014 Jul 30;29(8):1094–1101. doi: 10.3346/jkms.2014.29.8.1094

Table 5.

Multivariate analysis for NSCLC patients

graphic file with name jkms-29-1094-i005.jpg

*Cox proportional hazards regression analyses with a backward stepwise selection. NSCLC, non-small cell lung cancer; CSF, cerebrospinal fluid; EGFR-TKI, epidermal growth factor receptor-tyrosine kinase inhibitor; LM, leptomeningeal metastasis, HR, hazard ratio; CI, confidence interval.